US Representative

Anthony D'Esposito 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 10)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4339

Introduced
6/23/23  
Refer
6/23/23  
Preserving Local Medicaid Access Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4376

Introduced
6/27/23  
Refer
6/27/23  
Brianna Lieneck Boating Safety Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4384

Introduced
6/27/23  
Project Safe Neighborhoods Reauthorization Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4408

Introduced
6/30/23  
Refer
6/30/23  
Promising Pathway Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4438

Introduced
6/30/23  
Refer
6/30/23  
John W. Walsh Alpha-1 Home Infusion Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4442

Introduced
6/30/23  
Expanding Access to High-Impact Tutoring Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4563

Introduced
7/11/23  
Refer
7/11/23  
Refer
7/11/23  
ACE Act End Zuckerbucks Act of 2023 Solving an Overlooked Loophole in Votes for Executives (SOLVE) Act Promoting Free and Fair Elections Act Don't Weaponize the IRS Act American Confidence in Elections Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4571

Introduced
7/12/23  
Child Care Investment Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4581

Introduced
7/12/23  
Refer
7/12/23  
Refer
7/14/23  
Report Pass
3/20/24  
Engrossed
5/16/24  
Enrolled
7/8/24  
Passed
7/12/24  
Chaptered
7/12/24  
Maternal and Child Health Stillbirth Prevention Act of 2024
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB467

Introduced
1/24/23  
Refer
1/24/23  
Refer
1/24/23  
Report Pass
3/24/23  
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4709

Introduced
7/18/23  
U.S.-Israel Anti-Killer Drone Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4710

Introduced
7/18/23  
Refer
7/18/23  
POST FAST Act of 2023 Publish Overdose and Suicide Tracking For American Safety Today Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4756

Introduced
7/19/23  
Community News and Small Business Support Act

Primary Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4479

Introduced
7/6/23  
Positioning the Election Assistance Commission for the Future Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4701

Introduced
7/18/23  
Refer
7/18/23  
Protecting Americans from Fentanyl Trafficking Act of 2023